6H-嘌呤-6-酮 | 206067-84-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 中文名称: 6H-嘌呤-6-酮
• 英文名称: N²-(p-anisyldiphenylmethyl)-9-[(4-tosyl)-3-p-anisyldiphenylmethoxymethylbutyl]guanine
• 英文别名: [2-[[(4-methoxyphenyl)-diphenylmethoxy]methyl]-4-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-oxo-1H-purin-9-yl]butyl] 4-methylbenzenesulfonate
• CAS: 206067-84-7
• 化学式: C₅₇H₅₃N₅O₇S
• 分子量: 952.143
• InChiKey: GWOKTINUYGXEEE-UHFFFAOYSA-N

物化性质

• 熔点：
  200.2-203.8 °C
• 密度：
  1.23±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  10.3
• 重原子数：
  70
• 可旋转键数：
  20
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  151
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  6H-嘌呤-6-酮 在 potassium fluoride 、 4,7,13,16,21,24-六氧-1,10-二氮双环[8.8.8]二十六烷 作用下， 以 乙腈 为溶剂， 以69.1%的产率得到N2-(p-anisyldiphenylmethyl)-9-[(4-fluoro)-3-p-anisyldiphenylmethoxy-methylbutyl]guanine
  参考文献：
  名称：

  Novel radiosynthesis of PET HSV-tk gene reporter probes [18F]FHPG and [18F]FHBG employing dual Sep-Pak SPE techniques

  摘要：

  Positron emission tomography (PET) herpes simplex virus thymidine kinase (HSV-tk) gene reporter probes 9-[(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]FHPG) and 9-(4-[F-18]fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG) were prepared by nucleophilic substitution of the appropriate tosylated precursors with [F-18]KF/Kryptofix 2.2.2 followed by a quick deprotection reaction and purification with a simplified dual Silica Sep-Pak solid-phase extraction (SPE) method in 15-30% radiochemical yield. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.09.010
• 作为产物：
  描述：

  1,1,2-乙烷三羧酸三乙酯 在 吡啶 、 盐酸 、 4-二甲氨基吡啶 、 sodium tetrahydroborate 、 四溴化碳 、 potassium carbonate 、 对甲苯磺酸 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 叔丁醇 为溶剂， 生成 6H-嘌呤-6-酮
  参考文献：
  名称：

  Novel radiosynthesis of PET HSV-tk gene reporter probes [18F]FHPG and [18F]FHBG employing dual Sep-Pak SPE techniques

  摘要：

  Positron emission tomography (PET) herpes simplex virus thymidine kinase (HSV-tk) gene reporter probes 9-[(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]FHPG) and 9-(4-[F-18]fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG) were prepared by nucleophilic substitution of the appropriate tosylated precursors with [F-18]KF/Kryptofix 2.2.2 followed by a quick deprotection reaction and purification with a simplified dual Silica Sep-Pak solid-phase extraction (SPE) method in 15-30% radiochemical yield. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.09.010

文献信息

• Syntheses of novel modified acyclic purine and pyrimidine nucleosides as potential substrates of herpes simplex virus type-1 thymidine kinase for monitoring gene expression
  作者：Michaela Grote、Steffi Noll、Bernhard Noll、Bernd Johannsen、Werner Kraus

  DOI：10.1139/v04-005

  日期：2004.4.1

  Suicide gene therapy with the herpes simplex virus type-1 thymidine kinase gene (HSV-1 tk) is considered to be a promising approach to the treatment of cancer. Making use of the lower specificity of the viral enzyme compared to human thymidine kinase, the therapy involves the administration of antiviral agents (e.g., ganciclovir) as prodrugs to induce enzymatic cell death in those cells that express the transferred gene. ¹⁸F-labelled derivatives have been described for monitoring location, duration, and magnitude of the viral kinase enzyme activity by positron emission tomography (PET). Since an optimal radiotracer has not been developed, novel substances were synthesized for monitoring gene expression. A group of 13 nucleoside analogues were synthesized, among them N¹-methyl-9-[(1,3-dihydroxy-2-propoxy)methyl]guanine (5) and N¹-methyl-9-[(4-hydroxy)-3-hydroxymethylbutyl]guanine (7) as methyl analogues of ganciclovir and penciclovir and their related fluoro compounds (6, 8). Further novel derivatives include N⁶-methyl-9-[(1,3-dihydroxy-2-propoxy)methyl]-, N⁶-methyl-9-[(4-hydroxy)-3-hydroxymethylbutyl]adenine (9, 10), as well as the uracil derivatives 5-hydroxy-1-[(1,3-dihydroxy-2-propoxy)methyl]uracil (11), 6-methyl-1-[(1,3-dihydroxy-2-propoxy)-methyl]uracil (12), and its 3-fluoro-derivative (13).Key words: fluorinated nucleoside analogues, gene therapy, PET, thymidine kinase.

  自杀基因治疗利用单纯疱疹病毒1型胸腺嘧啶激酶基因（HSV-1 tk）被认为是治疗癌症的一种有前景的方法。该疗法利用病毒酶相对于人类胸腺嘧啶激酶的较低特异性，涉及向表达转移基因的细胞施加抗病毒药物（例如甘昔洛韦）作为前药，诱导这些细胞发生酶促细胞死亡。已经描述了¹⁸F标记的衍生物，用于通过正电子发射断层扫描（PET）监测病毒激酶酶活性的位置、持续时间和强度。由于尚未开发出最佳放射性示踪剂，因此合成了新颖的物质用于监测基因表达。合成了一组13个核苷类似物，其中包括N¹-甲基-9-[(1,3-二羟基-2-丙氧基)甲基]鸟苷（5）和N¹-甲基-9-[(4-羟基)-3-羟甲基丁基]鸟苷（7）作为甘昔洛韦和彭昔洛韦的甲基类似物及其相关的氟化合物（6，8）。进一步的新颖衍生物包括N⁶-甲基-9-[(1,3-二羟基-2-丙氧基)甲基]-，N⁶-甲基-9-[(4-羟基)-3-羟甲基丁基]腺嘌呤（9，10），以及尿嘧啶衍生物5-羟基-1-[(1,3-二羟基-2-丙氧基)甲基]尿嘧啶（11），6-甲基-1-[(1,3-二羟基-2-丙氧基)-甲基]尿嘧啶（12）及其3-氟衍生物（13）。关键词：氟化核苷类似物，基因治疗，PET，胸腺嘧啶激酶。
• Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
  申请人：Board of Regents, The University of Texas System

  公开号：US20040166058A1

  公开（公告）日：2004-08-26

  The invention provides, in a general sense, a new labeling strategy employing compounds that are are N 2 S 2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angiogenesis targeting ligand, a tumor apoptosis targeting ligand, a disease receptor targeting ligand, amifostine, angiostatin, monoclonal antibody C225, monoclonal antibody CD31, monoclonal antibody CD40, capecitabine, COX-2, deoxycytidine, fullerene, herceptin, human serum albumin, lactose, leuteinizing hormone, pyridoxal, quinazoline, thalidomide, transferrin, or trimethyl lysine. The present invention also pertains to kits employing the compounds of interest, and methods of assessing the pharmacology of an agent of interest using the present compounds.

  该发明提供了一种新的标记策略，采用将N2S2螯合物与靶向配体结合的化合物，其中靶向配体是疾病细胞周期靶向化合物、肿瘤血管生成靶向配体、肿瘤凋亡靶向配体、疾病受体靶向配体、氨基磷酸酯、抗血管生成素、单克隆抗体C225、单克隆抗体CD31、单克隆抗体CD40、卡培他滨、COX-2、脱氧胞苷、富勒烯、赫塞汀、人血清白蛋白、乳糖、黄体生成激素、吡ridoxal、喹唑啉、沙利度胺、转铁蛋白或三甲基赖氨酸。本发明还涉及使用感兴趣的化合物的试剂盒，以及利用本发明化合物评估感兴趣药剂的药理学方法。
• N2S2 chelate-targeting ligand conjugates
  申请人：Yang J. David

  公开号：US20050129619A1

  公开（公告）日：2005-06-16

  The invention provides, in a general sense, a new labeling strategy employing compounds that are are N 2 S 2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angiogenesis targeting ligand, a tumor apoptosis targeting ligand, a disease receptor targeting ligand, amifostine, angiostatin, monoclonal antibody C225, monoclonal antibody CD31, monoclonal antibody CD40, capecitabine, a COX-2 inhibitor, deoxycytidine, fullerene, herceptin, human serum albumin, lactose, leuteinizing hormone, pyridoxal, quinazoline, thalidomide, transferrin, or trimethyl lysine. The present invention also pertains to kits employing the compounds of interest, and methods of assessing the pharmacology of an agent of interest using the present compounds.

  该发明提供了一种新的标记策略，使用N2S2螯合物与靶向配体结合，其中靶向配体是疾病细胞周期靶向化合物、肿瘤血管生成靶向配体、肿瘤凋亡靶向配体、疾病受体靶向配体、氨磷汀、血管生成抑制素、单克隆抗体C225、单克隆抗体CD31、单克隆抗体CD40、卡培他滨、COX-2抑制剂、脱氧胞苷、富勒烯、赫塞汀、人血清白蛋白、乳糖、黄体生成激素、吡哆醛、喹唑啉、沙利度胺、转铁蛋白或三甲基赖氨酸。本发明还涉及使用感兴趣的化合物的试剂盒，以及使用本发明化合物评估感兴趣药物的药理学方法。
• Efficient synthesis of 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) and 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG)
  作者：Jie Liu、Jorge R. Barrio、Nagichettiar Satyamurthy

  DOI：10.1016/j.jfluchem.2017.08.007

  日期：2017.9

  A new, high radiochemical yield synthesis of [18F]FHBG and [18F]FHPG, the most popular imaging agents currently in use for monitoring gene therapy using positron emission tomography (PET), is reported in this work. Protection of sensitive sites in the precursors generally utilized for the preparation of [18F]FHBG and [18F]FHPG using the nucleophilic 18F-fluorination reaction was found to be critical

  这项工作报道了[ 18 F] FHBG和[ 18 F] FHPG的新的高放射化学收率合成，这是目前正用于监测使用正电子发射断层扫描（PET）进行基因治疗的最流行的成像剂。发现通常使用亲核的18 F-氟化反应来保护制备[ 18 F] FHBG和[ 18 F] FHPG的前体中的敏感位点，对于合成方法的良好放射化学收率，可靠性和可重复性至关重要。最初的方法是在当前使用的单甲氧基三苯甲基保护的喷昔洛韦甲苯磺酸酯衍生物9的鸟嘌呤部分的O 6氧处进行保护。与氨基甲酰基一起进行。随后，两者的充分保护ö 6 -氧和Ñ 2 -氮在单甲氧保护喷昔洛韦和更昔洛韦甲苯磺酸酯类似物9和10，通过它们的反应与二-实现叔丁基二碳酸酯，这导致ö 6 -叔-丁基- ñ 2 -Boc单甲氧保护的喷昔洛韦甲苯磺酸酯18和ö 6 -叔丁基- ñ 2 -Boc单甲氧保护的更昔洛韦甲苯磺酸酯19， 分别。首先将新合成的氨基甲酰基和Boc保护的前体与与Kryptofix
• 99mTc-EC-Guanine: Synthesis, Biodistribution, and Tumor Imaging in Animals
  作者：David J. Yang、Kaoru Ozaki、Chang-Sok Oh、Ali Azhdarinia、Thomas Yang、Megumi Ito、Allison Greenwell、Jerry Bryant、Saady Kohanim、Vincenzo K. Wong、E. Edmund Kim

  DOI：10.1007/s11095-005-6157-8

  日期：2005.9

  DNA markers are useful in assessing cell proliferation. The purpose of this study was to synthesize 99mTc-ethylenedicysteine-guanine (EC-Guan) for evaluation of cell proliferation. Tumor cells were incubated with 99mTc-EC-Guan for cell cycle analysis. Prostate tumor cells that were overexpressing the HSV thymidine kinase gene, or various tumor cells were incubated with 99mTc-EC-Guan at 0.5–2 h. Thymidine incorporation assays were performed in lung cancer cells incubated with EC-Guan at 0.1–1 mg/well. Tissue distribution, autoradiography, and planar scintigraphy of 99mTc-EC-Guan and 99mTc-EC (control) were determined in tumor-bearing rodents at 0.5–4 h. Cell culture assays indicated that EC-Guan was incorporated in DNA, and there was no significant uptake difference between HSVTK overexpressed and normal groups. Biodistribution and scintigraphic imaging studies of 99mTc-EC-Guan showed increased tumor/tissue count density ratios as a function of time. Our results indicate that 99mTc-EC-Guan may be useful as a tumor proliferation imaging agent.

  DNA 标记有助于评估细胞增殖。本研究的目的是合成用于评估细胞增殖的 99m锝-乙二半胱氨酸鸟嘌呤（EC-Guan）。肿瘤细胞与 99mTc-EC-Guan 一起孵育，进行细胞周期分析。将过表达 HSV 胸苷激酶基因的前列腺肿瘤细胞或各种肿瘤细胞与 99mTc-EC-Guan 培养 0.5-2 h 。用 0.1-1 mg/well 浓度的 EC-Guan 培养肺癌细胞，进行胸苷掺入试验。在 0.5-4 h 时，测定了肿瘤啮齿动物体内 99mTc-EC-Guan 和 99mTc-EC （对照组）的组织分布、自显影和平面闪烁成像。细胞培养试验表明，EC-Guan与DNA结合，HSVTK过表达组与正常组之间没有明显的摄取差异。99mTc-EC-Guan 的生物分布和闪烁成像研究显示，肿瘤/组织计数密度比随时间的变化而增加。我们的研究结果表明，99m锝-EC-Guan 可作为一种肿瘤增殖成像剂。